User profiles for Ted Smith

Ted Smith

Associate Professor of Environmental Medicine
Verified email at louisville.edu
Cited by 1700

Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo …

…, WJG Hellstrom, CG McMahon, T Smith… - The Journal of …, 2013 - auajournals.org
Purpose : IMPRESS (Investigation for Maximal Peyronie's Reduction Efficacy and Safety
Studies) I and II examined the clinical efficacy and safety of collagenase Clostridium …

Reconsidering models of influence: the relationship between consumer social networks and word-of-mouth effectiveness

T Smith, JR Coyle, E Lightfoot… - Journal of …, 2007 - journalofadvertisingresearch.com
In today's fragmented media landscape, generating positive word of mouth (WOM) among
consumers has become an important tool for marketers. Marketers are challenged with …

[HTML][HTML] Wastewater surveillance of pathogens can inform public health responses

…, KG Kuhn, CL Moe, EC Rouchka, T Smith… - Nature Medicine, 2022 - nature.com
Wastewater monitoring has been used to identify SARS-CoV-2 outbreaks and track new
variants. This sentinel system should be expanded to monitor other pathogens and boost …

Clarithromycin Therapy for Bacteremic Mycobacterium avium Complex Disease: A Randomized, Double-Blind, Dose-Ranging Study in Patients with AIDS

…, LB Heifets, JA Korvick, S Elkin, T Smith… - Annals of internal …, 1994 - acpjournals.org
Objective: To determine the antimicrobial activity and tolerability of clarithromycin for
treating bacteremic Mycobacterium avium complex disease in patients with the acquired …

[BOOK][B] Challenging the chip: Labor rights and environmental justice in the global electronics industry

T Smith, DA Sonnenfeld, DN Pellow - 2006 - books.google.com
… Library of Congress Cataloging-in-Publication Data Challenging the chip: labor rights
and environmental justice in the global electronics industry / edited by Ted Smith, David A. …

Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long …

…, P Blazar, S Coleman, FTD Kaplan, T Smith… - The Journal of hand …, 2015 - Elsevier
Purpose Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety
Study was a 5-year noninterventional follow-up study to determine long-term efficacy and …

Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire

…, R Feldman, RC Rosen, T Smith… - The Journal of …, 2013 - auajournals.org
Purpose : We validated the Peyronie's Disease Questionnaire ( http://www.auxilium.com/PDQ
), a 15-question self-reported survey that measures the impact and severity of Peyronie's …

Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data

…, P Blazar, S Coleman, FTD Kaplan, T Smith… - The Journal of hand …, 2013 - Elsevier
PURPOSE: To evaluate long-term efficacy and safety of collagenase clostridium histolyticum
(CCH) after the third year of a 5-year nontreatment follow-up study, Collagenase Option for …

[HTML][HTML] High-throughput sequencing of SARS-CoV-2 in wastewater provides insights into circulating variants

…, WK Holmes, S Deitrick, P Brown, D Duty, T Smith… - Water Research, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) likely emerged from a zoonotic
spill-over event and has led to a global pandemic. The public health response has been …

Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease

M Gelbard, LI Lipshultz, J Tursi, T Smith… - The Journal of …, 2012 - auajournals.org
Purpose : Collagenase Clostridium histolyticum is an investigational nonsurgical treatment
for Peyronie disease. In this phase 2b, double-blind, randomized, placebo controlled study …